Blood Product Transfusion Monitoring - NCLEX-PN

Fever/chills, flank/back pain, hypotension, hemoglobinuria. These symptoms result from ABO incompatibility causing rapid red cell destruction and systemic response.

Chills. Chills may indicate a febrile or hemolytic reaction requiring prompt intervention, unlike mild hunger which is unrelated.

Stop the transfusion immediately. Prevents further antigen exposure and potential worsening of the reaction, prioritizing patient safety.

Keep IV open with 0.9% normal saline using new tubing. Maintains venous access for emergency interventions while avoiding further blood infusion and contamination.

Baseline, 15 min after start, then per policy (often hourly), and at end. Allows early detection of reactions, as most occur soon after initiation, with ongoing monitoring for changes.

Dyspnea with hypertension and crackles (fluid overload). Indicates pulmonary edema from excessive volume overwhelming cardiac capacity in at-risk patients.

Plasma-containing products (especially platelets or plasma). These products contain donor proteins that can trigger IgE-mediated hypersensitivity in recipients.

Stop temporarily; give antihistamine per order; restart if symptoms resolve. Mild allergic reactions can often be managed without permanent discontinuation if symptoms abate after treatment.

Wheezing/stridor with hypotension. Represents severe allergic response with airway compromise and shock, necessitating immediate epinephrine and support.

Febrile: fever/chills only; hemolytic: hypotension, back pain, hemoglobinuria. Febrile reactions are benign cytokine-mediated, while hemolytic involves destructive antibody response with systemic effects.

Two-identifier patient match to blood product label and compatibility. Ensures prevention of clerical errors, the most common cause of hemolytic reactions, through dual verification.

0.9% normal saline only. Isotonic saline prevents hemolysis or clotting, unlike other solutions that may damage red cells.

Large-bore IV, typically 18–20 gauge. Facilitates adequate flow rate without causing red cell hemolysis from excessive pressure in smaller gauges.

Use blood administration set with in-line filter. Filters remove microaggregates and debris, reducing risk of reactions while ensuring safe administration.

Complete within 4 hours. Minimizes bacterial proliferation risk in blood at room temperature, adhering to safety standards.

Begin within 30 minutes of receiving the unit (per common policy). Prevents bacterial growth by limiting exposure time outside controlled refrigeration.

High fever with rigors and hypotension during transfusion. Indicates bacterial endotoxin release causing septic shock, a rare but life-threatening complication.

Send blood bag and tubing to the blood bank per protocol. Allows laboratory analysis to identify reaction cause and prevent future errors.

Blood and urine samples for hemolysis workup per protocol. Detects free hemoglobin and other markers confirming intravascular hemolysis from incompatibility.

Start/stop times, product ID, rate, vital signs, and patient response. Provides legal record of procedure adherence and early detection of adverse events for quality care.

“I feel back pain.”. Back pain signals possible hemolytic reaction from kidney involvement, unlike fatigue which may be nonspecific.

Stop transfusion, place upright, administer oxygen and diuretic as ordered. Reduces fluid overload effects by stopping infusion, improving breathing, and promoting diuresis as needed.

Acute hypoxemia with hypotension and noncardiogenic pulmonary edema. TRALI involves immune-mediated lung injury without cardiac involvement, differing from TACO's volume-related hypertension.

Stop transfusion and assess for TACO/TRALI; apply oxygen. Addresses potential pulmonary complications like overload or injury by halting cause and supporting oxygenation.